EquityBulls

Latest News

Reliance Power Ltd clarifies on provisional attachment of assets by ED
Fino becomes India's first Payments Bank to receive 'In-principle' approval from RBI for conversion into a Small Finance Bank
Fire at Aditya Vision Ltd's warehouse
Shriram Pistons & Rings Ltd announces Definitive Agreement to acquire 100% stake in Antolin Group's Indian Operations
Supreme Petrochem Ltd announces temporary closure of plant at Manali, Chennai

Keywords Selected: Pharmaceuticals

Research

IPO News

Stock Report

EDQM issues CEP Certificate for MINOXIDIL to IOL Chemicals & Pharmaceuticals Ltd
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Anuh Pharma Ltd granted CEP from EDQM for Sulfadimethoxine
Lupin receives tentative approval from U.S. FDA for Siponimod Tablets
Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
Zydus receives EIR for the injectable facility located at Jarod
Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
SPARC announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV
Appointment of Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc.
Granules India Strengthens R&D Leadership with Two New Centres of Excellence at IIT Hyderabad's Technology Research Park
US FDA Accepts Wockhardt's New Drug Application for Breakthrough Antibiotic Zaynich
Venus Remedies Ltd update on resolution Of Income Tax matters and Elimination of Contingent Liability
Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
Cipla Launches India's First Dedicated Lung Health Diagnostics Center in Delhi
Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm
Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
Lupin Foundation Earns CRISIL's Highest VO 1A Rating for Excellence in Social Responsibility
Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg
Glenmark Pharmaceuticals Receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility
SMS Pharmaceutical's associate company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine
Zydus and RK Pharma enter into an exclusive licensing and commercialization agreement for a novel 505(b)(2) product of supportive oncology treatment for the USA market
Amrutanjan Healthcare Partners with Kaun Banega Crorepati to Celebrate 132 Years of Trust and Wellness

Industry News

NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India